Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcript profiling of Lymphangioleiomyomatosis (LAM) nodules in Human Patients


ABSTRACT: Lymphangioleiomyomatosis (LAM) is characterized by cystic lung destruction caused by smooth, muscle-like LAM cells which have mutations in the tumor suppressor genes Tuberous Sclerosis Complex (TSC) 1 or 2, and the capacity to metastasize. Since chemokines and their receptors function in chemotaxis of metastatic cells, we hypothesized that LAM cells may be recruited by chemokine(s) in the lung. Quantification of 25 chemokines in bronchoalveolar lavage fluid from LAM patients and healthy volunteers revealed that concentrations of MCP-1/CCL2, GROa/CXCL1 and ENA-78/CXCL5 were significantly higher in samples from LAM patients than healthy volunteers. In this transcript analysis, expression of chemokine and chemokine receptor mRNA in LAM cells differed from those in melanoma and smooth muscle cells. Subsequent immunohistochemistry of lung sections from 30 LAM patients confirmed protein expression of chemokines and these receptors varied among LAM patient and differed from that seen in breast cancer and melanoma cells. . In vitro, MCP-1/CCL2 induced selective migration of cells showing loss of heterozygosity of TSC2 from a heterogeneous populations of cells grown from explanted LAM lungs. In addition, the frequencies of single-nucleotide polymorphisms in the MCP-1 gene promoter region differed significantly in LAM patients and healthy volunteers (p=0.018), and one polymorphism was associated significantly more frequently with the decline of lung function. These observations are consistent with the notion that chemokines such as MCP-1 may serve to specify site of LAM cell metastasis. Keywords: Human patient sample comparison with cell lines The study is of case/control design with biological replication. Biopsies of nodules from 14 LAM patients (cases) are compared with cultured cell lines (controls) with similar properties.

ORGANISM(S): Homo sapiens

SUBMITTER: Eric Billings 

PROVIDER: E-GEOD-12027 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.

Pacheco-Rodriguez Gustavo G   Kumaki Fumiyuki F   Steagall Wendy K WK   Zhang Yi Y   Ikeda Yoshihiko Y   Lin Jing-Ping JP   Billings Eric M EM   Moss Joel J  

Journal of immunology (Baltimore, Md. : 1950) 20090201 3


Lymphangioleiomyomatosis (LAM) is characterized by cystic lung destruction caused by LAM cells (smooth-muscle-like cells) that have mutations in the tumor suppressor genes tuberous sclerosis complex (TSC) 1 or 2 and have the capacity to metastasize. Since chemokines and their receptors function in chemotaxis of metastatic cells, we hypothesized that LAM cells may be recruited by chemokine(s) in the lung. Quantification of 25 chemokines in bronchoalveolar lavage fluid from LAM patients and health  ...[more]

Similar Datasets

2008-12-31 | GSE12027 | GEO
2010-07-01 | E-FPMI-5 | biostudies-arrayexpress
2017-04-15 | GSE97835 | GEO
2012-11-19 | E-GEOD-36331 | biostudies-arrayexpress
2021-12-31 | GSE160618 | GEO
2012-11-19 | GSE36331 | GEO
2020-04-08 | PXD015845 | Pride
2008-10-25 | E-GEOD-12627 | biostudies-arrayexpress
2013-04-09 | E-GEOD-43075 | biostudies-arrayexpress
2019-05-18 | GSE131383 | GEO